Susquehanna And Affiliates Report 6.6% Strive Position With Millions Of Shares In Options
The affiliated broker-dealers certified ordinary-course holdings without a purpose of changing or influencing Strive's control.
Susquehanna Securities and affiliated broker-dealers reported a joint 6.6% position in Strive, a structured finance company and institutional asset manager that holds bitcoin as a treasury asset. Their SEC ownership disclosure filed Monday covered 5,884,324 Class A shares as of September 30, 2026, including options exposure.
Options Account For Much Of Susquehanna's Holding
Susquehanna Securities' reported holding includes purchase options covering 5,001,631 shares. SIG Brokerage, an affiliated independent broker-dealer joining the disclosure, reported a holding consisting entirely of options to buy shares.
The percentage uses an ownership-rule measure that includes those options. Strive had 88,814,706 Class A shares outstanding as of September 30, 2026, a figure the brokers cited from the company's quarterly report filed November 6.
A Joint Position Across Broker-Dealers
G1 Execution Services, another affiliated independent broker-dealer, joined Susquehanna Securities and SIG Brokerage in reporting the position. The firms said they may be treated as a group for ownership-reporting purposes.
Each reported shared voting and disposal power over the joint 5,884,324-share position. Susquehanna Securities reported sole voting power over 5,847,587 shares; G1 Execution Services reported 26,737, and SIG Brokerage reported 10,000.
The firms attributed sole voting and disposal power to their respective holdings, while each disclaimed ownership of shares directly held by the others. The repeated joint total therefore belongs to the reporting group.
Bitcoin, Asset Management And Blood-Flow Testing
Strive partly finances bitcoin purchases by selling SATA Stock, its perpetual preferred equity, through an at-the-market program. Its bitcoin treasury stood at 13,628 bitcoin as of March 17, 2026.
The asset management business earns fees that increase with assets under management, which exceeded $2.4 billion as of December 31, 2025.
Strive also owns a healthcare technology business through its January 16, 2026 merger with Semler Scientific. That business markets QuantaFlo, an FDA-cleared blood-flow test used in offices, mainly through licenses to insurance plans, hospital and physician groups, and doctors' offices.
The reporting firms certified that they acquired and held the securities in the ordinary course of business, without a purpose or effect of changing or influencing Strive's control.